AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 212 min read$CME

CME Group (NASDAQ:CME) Surprises With Q3 2026 Sales

CME Group reported Q3 2026 revenue of $1.74 billion, up 13% YoY and exceeding estimates by 0.9%. Despite beating revenue expectations, EBITDA missed forecasts, and the stock remained flat at $292.74 post-results.

Original reporting
finance.yahoo.com
Published Oct 21, 2026, 11:31 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
CME Group (NASDAQ:CME) Surprises With Q3 2026 Sales — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$CMENeutralMed
01

Why it matters

The mixed earnings result may keep the stock range‑bound as investors weigh revenue strength against profitability concerns.

02

Market read

First‑time earnings disclosure with material revenue beat; modest trading relevance.

03

What to watch

Potential future growth from the highlighted hidden platforms could offset short‑term earnings weakness.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

CME Group is a leading derivatives exchange operator; its earnings are closely watched for insights into market activity and pricing power.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

CME Group reported Q3 2026 revenue of $1.74 B, up 13% YoY and beating estimates by 0.9%, marking the first public disclosure of these results.

Expected impact

likely modest pressure as market digests mixed results

Evidence & confidence

First earnings release with solid revenue beat but weak earnings; investors may be cautious.

Market effects

Sector

Strong revenue growth may signal resilience in the derivatives exchange sector.

Regional

Limited impact beyond U.S. financial markets.

Global

Modest relevance; CME is a key global market infrastructure provider.

Counterpoint

What could challenge this read

Despite revenue beat, the EBITDA miss could indicate underlying cost pressures, suggesting a short‑term downside.

Key entities

  • Company
    CME Group

    NASDAQ‑listed derivatives exchange operator.

Read at source← All news

StoryCME Group posts record Q3 revenue and adjusted EPS beat, but shares dip on guidance concerns

Also covered by

6 outlets

Related articles

OCT 21
$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

marketscreener.com3 min
OCT 21
$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

marketscreener.com2 min
OCT 21
$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.

gurufocus.com2 min